Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy
X-linked myotubular myopathy (XLMTM) is a severe muscle disease with no effective treatment. Here, the authors show that tamoxifen, a drug used to treat breast cancer, rescues the pathology in a mouse model of the disease, at least in part by normalizing expression of the disease modifier proteins D...
Guardado en:
Autores principales: | Elinam Gayi, Laurence A. Neff, Xènia Massana Muñoz, Hesham M. Ismail, Marta Sierra, Thomas Mercier, Laurent A. Décosterd, Jocelyn Laporte, Belinda S. Cowling, Olivier M. Dorchies, Leonardo Scapozza |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/55e31f0f62ce4d928b4e2b13a82b1d60 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances
por: Raquel Gómez-Oca, et al.
Publicado: (2021) -
Tamoxifen therapy in a murine model of myotubular myopathy
por: Nika Maani, et al.
Publicado: (2018) -
Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice
por: Hichem Tasfaout, et al.
Publicado: (2017) -
Integrative data mining highlights candidate genes for monogenic myopathies.
por: Osorio Abath Neto, et al.
Publicado: (2014) -
Atrial Myopathy Underlying Atrial Fibrillation
por: Harold Rivner, et al.
Publicado: (2020)